Doxycycline: Are Its 'Side-effects' a Contra-indication to Its Use?

نویسندگان

  • NM KING
  • HM WONG
  • VLN KUMAR
چکیده

Received July 10, 2006 Abstract Objectives: To briefly outline the development and reasons for the decline in the clinical use of tetracyclines, and to consider if the side-effects of doxycycline a contra-indication to its use. Data Sources: Literature search of MEDLINE from 1950 to 2005. Study Selection: Literature and data related to doxycycline, tetracycline and tooth discolouration. Data Extraction: Relevant information and data were reviewed by the authors. Data Synthesis: The established side-effect of tooth discolouration has led to the formation of guidelines to restrict the use of the tetracyclines in susceptible groups of patients, such as pregnant women and throughout childhood. The severity of the discolouration is likely to be related to the different homologues of the tetracyclines, dose, frequency, the stage of odontogenesis, and the duration of the therapy. The majority of published clinical data indicates that doxycycline can be prescribed for children because it causes the least severe type of tooth discolouration. However, there has not been a prospective, randomised, double blind study that compared doxycycline with other tetracyclines to make a definitive statement about the decreased incidence of dental discolouration by doxycycline. The propriety of carrying out a clinical trial using doxycycline involving children when the side-effects of tetracyclines are already well known is also disputable. Conclusions: Caution should be exercised when prescribing doxycycline to children who should be kept under long term review because of the insufficient data concerning the discolouration of the developing teeth.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی مقایسه‌ای اثر درمانی داکسی‌سایکلین و آزیترومایسین در سرویسیت کلامیدیایی

 Introduction: Considering the high spread of Chlamydia cervicitis in Iran and its undesirable side-effects on women’s and their families’ health through causing infertility and transmitting it to the spouse and its bad economic impacts on the community, a remedy for this infection seems to be necessary. Considering the common remedial treatment (100mg of Doxycycline twice a day for 7 days).  A...

متن کامل

Evaluation the protective effects of doxycycline on acetaminophen-induced hepatotoxicity in mice

Acetaminophen (APAP) toxicity threatens human health due to increased mortality associated with its overdose. Doxycycline (DC) because of its properties such as antioxidant and anti-inflammatory can be a good therapeutic strategy to treat the acute toxicity induced by APAP. Male mice were divided to six groups in two periods of 3 and 24-h as normal saline, APAP 400 mg/kg, DC 100 mg/kg and group...

متن کامل

Evaluation the protective effects of doxycycline on acetaminophen-induced hepatotoxicity in mice

Acetaminophen (APAP) toxicity threatens human health due to increased mortality associated with its overdose. Doxycycline (DC) because of its properties such as antioxidant and anti-inflammatory can be a good therapeutic strategy to treat the acute toxicity induced by APAP. Male mice were divided to six groups in two periods of 3 and 24-h as normal saline, APAP 400 mg/kg, DC 100 mg/kg and group...

متن کامل

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker

Mexiletine as the first choice drug in myotonia treatment is a chiral sodium channel blocker clinically used in its racemic form. The phenolic structure of this drug, prompted us to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the synthesis and in-vitro anti-myotonic activity of the chalice-shaped cluster of mexiletine...

متن کامل

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker

Mexiletine as the first choice drug in myotonia treatment is a chiral sodium channel blocker clinically used in its racemic form. The phenolic structure of this drug, prompted us to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the synthesis and in-vitro anti-myotonic activity of the chalice-shaped cluster of mexiletine...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007